A5090289865- Cancer Cells and Metastasis
- Immune cells in cancer
- Barrier Structure and Function Studies
- RNA Interference and Gene Delivery
- Neurogenesis and neuroplasticity mechanisms
- Immunotherapy and Immune Responses
- MicroRNA in disease regulation
- Hematopoietic Stem Cell Transplantation
- Cancer, Stress, Anesthesia, and Immune Response
- Multiple Sclerosis Research Studies
- Platelet Disorders and Treatments
- Mesenchymal stem cell research
- Stress Responses and Cortisol
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Electroconvulsive Therapy Studies
- Hippo pathway signaling and YAP/TAZ
- Cell Image Analysis Techniques
- Antibiotic Use and Resistance
- Long-Term Effects of COVID-19
- Nanoplatforms for cancer theranostics
- Chronic Myeloid Leukemia Treatments
- Bone Metabolism and Diseases
- Vagus Nerve Stimulation Research
- Axon Guidance and Neuronal Signaling
- Nanoparticle-Based Drug Delivery
Universidade Federal do Rio de Janeiro
2025
Universidade Federal de Minas Gerais
2017-2022
The tumour mass is composed not only of heterogeneous neoplastic cells, but also a variety other components that may affect cancer cells behaviour. lack detailed knowledge about all the constituents microenvironment restricts design effective treatments. Nerves have been reported to contribute growth and maintenance numerous tissues. effects sensory innervations on remain unclear. Here, by using state-of-the-art techniques, including Cre/loxP technologies, confocal microscopy, in...
Objectives The aim of the study were to describe practice electroconvulsive therapy (ECT) at Institute Psychiatry (IPUB) Federal University Rio de Janeiro (UFRJ) from 2015 2019 and compare it with previous years same institute international practices. Methods Sociodemographic epidemiological data, along information on ECT anesthetic techniques, collected medical records all patients who received IPUB-UFRJ between 2019. Results A total 238 underwent 4110 sessions during period. slight...
The FDA-approved Dimethyl Fumarate (DMF) as an oral drug for Multiple Sclerosis (MS) treatment based on its immunomodulatory activities. However, it also caused severe adverse effects mainly related to the gastrointestinal system.